论文部分内容阅读
目的:讨论MRI、MRS对鉴别前列腺癌和前列腺增生的诊断价值。方法:本次目标性选取我院2013年9月至2016年09月期间确认患有前列腺疾病的患者55例,平均年龄在(59.3±13.9)岁,其中前列腺增生患者29例,前列腺癌患者26例;进行MRI和MRS检查,MRI分析横断面T2WI上外周带信号是否正常,外周带与中央带的自然分界是否存在等,对于MRS成像分析C峰、CC峰的高度变化情况;以诊断的正确率为观察指标。结果:对于前列腺癌患者,MRI诊断的正确率为65.39%,MRS诊断正确率为88.46%;对于前列腺增生患者来说,MRI诊断正确率为79.31%,MRS诊断正确率为82.76%。结论:前列腺癌和前列腺增生运用MRI和MRS检查诊断正确率高、操作简便、安全有效,值得在临床上推广和使用。
Objective: To discuss the diagnostic value of MRI and MRS in differential diagnosis of prostate cancer and benign prostatic hyperplasia. Methods: Fifty-five patients with benign prostatic diseases were selected from our hospital from September 2013 to September 2016, with a mean age of (59.3 ± 13.9) years, including 29 cases of benign prostatic hyperplasia and 26 cases of prostatic cancer Cases; MRI and MRS examination, MRI T2WI cross-sectional signal on the peripheral zone is normal, the outer zone and the central zone of the natural boundaries exist, for MRS imaging C peak, CC peak height changes; the diagnosis is correct Rate of observation. Results: For prostate cancer patients, the correct rate of MRI diagnosis was 65.39%, and the correct rate of MRS diagnosis was 88.46%. For benign prostatic hyperplasia, the correct rate of MRI diagnosis was 79.31% and the correct rate of MRS diagnosis was 82.76%. Conclusion: The diagnosis of prostate cancer and benign prostatic hyperplasia using MRI and MRS diagnostic accuracy is high, easy to operate, safe and effective, it is worth in the clinical promotion and use.